losartan has been researched along with losartan potassium in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (44.00) | 18.2507 |
| 2000's | 10 (40.00) | 29.6817 |
| 2010's | 3 (12.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, SZ; Atwal, KS; Bird, JE; Delaney, CL; Dickinson, KE; Ferrara, FN; Hedberg, A; Miller, AV; Moreland, S; O'Reilly, BC | 1 |
| Aronoff, GR; Brier, ME; Bunke, CM; Lathon, PV | 1 |
| Hartmann, A; Midtvedt, K; Stokke, ES | 1 |
| Altun, B; Arici, M; Cağlar, S; Turgan, C; Yasavul, U | 1 |
| Julian, BA; Mrug, M; Prchal, JF; Prchal, JT; Stopka, T | 1 |
| Barker, CV; Brantley, RR; Curtis, JJ; Gaston, RS; Julian, BA; Lee, JY; Prchal, JT; Stopka, T | 1 |
| Bresson-Vautrin, C; Chalopin, JM; Ducloux, D; Fournier, V | 1 |
| Fernández, A; Hortal, L; Lorenzo, M; Losada, A; Palop, L; Plaza, C; Rodríguez, JC; Vega, N | 1 |
| Lang, SM; Schiffl, H | 1 |
| Freudenthaler, SM; Gleiter, CH; Lucht, I; Schenck, T | 1 |
| Freudenthaler, SM; Gleiter, CH; Körner, T; Schreeb, K | 1 |
| Brink, M; Freudenthaler, SM; Gleiter, CH; Lucht, I; Schenk, T | 1 |
| Furuhashi, M; Hishida, A; Kato, A; Maruyama, Y; Takahashi, T; Takita, T | 1 |
| Goh, J; Lam, CW; Li, PK; Lui, SF; Wang, AY; Yu, AW; Yu, LM | 1 |
| Donnelly, SM; Miller, JA | 1 |
| Armada, E; Gayoso, P; Otero Glz, A; Pérez Melón, C | 1 |
| Bilen, H; Cetinkaya, R; Keles, S; Odabas, AR; Selcuk, Y | 1 |
| Falkay, G; Gaspar, R; Resch, BE; Sonkodi, S | 1 |
| Furukawa, T; Hayashi, M; Homma, K; Ichihara, A; Kaneshiro, Y; Kanno, Y; Saruta, T; Takemitsu, T; Takenaka, T; Yoshizawa, M | 1 |
| Agharazii, M; Larivière, R; Lebel, M; Rodrigue, ME | 1 |
| Anker, SD; Belonje, AM; Dickstein, K; Ponikowski, P; van Veldhuisen, DJ; von Haehling, S; Voors, AA; Westenbrink, BD | 1 |
| Hotta, H; Ishikawa, S; Itoh, T; Kim, SJ; Kuno, A; Maeda, T; Miki, T; Miura, T; Satoh, T; Shimamoto, K; Tanno, M; Terashima, Y; Togashi, N; Yano, T | 1 |
| Hemmelder, MH; Kluin-Nelemans, HC; Laverman, GD; Navis, G; Sinkeler, SJ; Slagman, MC; Vogt, L; Waanders, F | 1 |
| Thornton, SN | 1 |
| Bar-Klein, G; Friedman, A; Hameed, MQ; Jozwiak, S; Kaminski, RM; Klein, P; Klitgaard, H; Koepp, M; Löscher, W; Prince, DA; Rotenberg, A; Twyman, R; Vezzani, A; Wong, M | 1 |
1 review(s) available for losartan and losartan potassium
| Article | Year |
|---|---|
Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy?
Topics: Acetylcysteine; Animals; Anticonvulsants; Antioxidants; Atorvastatin; Brain Injuries, Traumatic; Ceftriaxone; Dibenzazepines; Drug Repositioning; Epilepsy; Epilepsy, Post-Traumatic; Erythropoietin; Fingolimod Hydrochloride; GABA Agents; Gabapentin; Humans; Immunologic Factors; Inflammation; Interleukin 1 Receptor Antagonist Protein; Isoflurane; Levetiracetam; Losartan; Neuroprotective Agents; Oxidative Stress; Pregabalin; Pyrrolidinones; Sirolimus; Stroke; Topiramate; Translational Research, Biomedical; Vigabatrin | 2020 |
11 trial(s) available for losartan and losartan potassium
| Article | Year |
|---|---|
Losartan, an angiotensin II type 1 receptor antagonist, lowers hematocrit in posttransplant erythrocytosis.
Topics: Angiotensin Receptor Antagonists; Erythropoietin; Female; Hematocrit; Humans; Kidney Transplantation; Losartan; Male; Polycythemia; Postoperative Complications | 1998 |
Losartan versus ramipril in the treatment of postrenal transplant erythrocytosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Erythrocyte Count; Erythropoietin; Hematocrit; Humans; Kidney Transplantation; Losartan; Polycythemia; Postoperative Complications; Ramipril; Reticulocyte Count; Transferrin | 1998 |
Losartan and anaemia of end-stage renal disease.
Topics: Anemia; Antihypertensive Agents; Erythropoietin; Humans; Hypertension; Kidney Failure, Chronic; Losartan; Prospective Studies | 1998 |
Fenoterol stimulates human erythropoietin production via activation of the renin angiotensin system.
Topics: Adrenergic beta-Agonists; Adult; Antihypertensive Agents; Cross-Over Studies; Double-Blind Method; Drug Interactions; Erythropoietin; Fenoterol; Humans; Losartan; Male; Renin-Angiotensin System; Time Factors | 1999 |
Angiotensin II increases erythropoietin production in healthy human volunteers.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Erythropoietin; Heart Rate; Hematocrit; Hemoglobins; Hemorrhage; Humans; Infusions, Intravenous; Losartan; Male; Phlebotomy; Placebos | 1999 |
Dose-dependent effect of angiotensin II on human erythropoietin production.
Topics: Adolescent; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Area Under Curve; Dose-Response Relationship, Drug; Drug Combinations; Erythropoietin; Humans; Losartan; Male; Osmolar Concentration; Renin; Time Factors; Vasoconstrictor Agents | 2000 |
No effect of losartan on response to erythropoietin therapy in patients undergoing hemodialysis.
Topics: Anemia; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Interactions; Erythropoietin; Female; Humans; Kidney Failure, Chronic; Losartan; Male; Middle Aged; Recombinant Proteins; Renal Dialysis | 2000 |
Losartan may modulate erythropoietin production.
Topics: Adult; Angiotensin II; Antihypertensive Agents; Blood Pressure; Erythropoietin; Female; Glomerular Filtration Rate; Humans; Losartan; Male; Renin-Angiotensin System; Sodium; Vasoconstrictor Agents; Water-Electrolyte Balance | 2001 |
The effect of high dose losartan on erythropoietin resistance in patients undergoing haemodialysis.
Topics: Adult; Amlodipine; Anemia; Angiotensin Receptor Antagonists; Antihypertensive Agents; Dose-Response Relationship, Drug; Drug Resistance; Erythropoietin; Female; Humans; Hypertension; Kidney Failure, Chronic; Losartan; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Renal Dialysis | 2003 |
Low doses of losartan and trandolapril improve arterial stiffness in hemodialysis patients.
Topics: Aged; Anemia; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Comorbidity; Dinoprost; Drug Therapy, Combination; Erythropoietin; Female; Follow-Up Studies; Hematocrit; Humans; Hyperlipidemias; Indoles; Kidney Failure, Chronic; Lipids; Lipoproteins; Lipoproteins, LDL; Losartan; Male; Middle Aged; Prospective Studies; Renal Dialysis; Treatment Outcome; Vascular Resistance | 2005 |
Erythropoietin is reduced by combination of diuretic therapy and RAAS blockade in proteinuric renal patients with preserved renal function.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Drug Therapy, Combination; Erythropoietin; Female; Humans; Hydrochlorothiazide; Kidney; Losartan; Male; Middle Aged; Proteinuria | 2010 |
13 other study(ies) available for losartan and losartan potassium
| Article | Year |
|---|---|
Dihydropyrimidine angiotensin II receptor antagonists.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Imidazoles; Losartan; Male; Pyrimidines; Rats; Rats, Inbred SHR; Structure-Activity Relationship; Tetrazoles | 1992 |
Erythropoietin-induced antinatriuresis mediated by angiotensin II in perfused kidneys.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Captopril; Dose-Response Relationship, Drug; Erythropoietin; Imidazoles; In Vitro Techniques; Kidney; Losartan; Male; Natriuresis; Perfusion; Rats; Rats, Wistar; Tetrazoles | 1993 |
Successful long-term treatment of post-transplant erythrocytosis with losartan.
Topics: Adult; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Erythropoietin; Female; Hematocrit; Hemoglobins; Humans; Imidazoles; Kidney Transplantation; Losartan; Polycythemia; Tetrazoles; Time Factors | 1996 |
Role of erythropoietin in pathogenesis of post transplant erythrocytosis (PTE) and mechanism of losartan's efficiency.
Topics: Antihypertensive Agents; Biphenyl Compounds; Erythropoietin; Humans; Imidazoles; Kidney Transplantation; Losartan; Polycythemia; Tetrazoles | 1997 |
Angiotensin II stimulates proliferation of normal early erythroid progenitors.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Cell Differentiation; Cells, Cultured; Erythroid Precursor Cells; Erythropoiesis; Erythropoietin; Gene Expression; Gene Expression Regulation, Developmental; Humans; Losartan; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Receptors, Erythropoietin; RNA, Messenger | 1997 |
Long-term follow-up of renal transplant recipients treated with losartan for post-transplant erythrosis.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Erythropoiesis; Erythropoietin; Female; Follow-Up Studies; Hematocrit; Humans; Kidney Transplantation; Losartan; Male; Middle Aged; Renin | 1998 |
Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosis.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Enalapril; Erythropoietin; Female; Hemoglobins; Humans; Insulin-Like Growth Factor I; Kidney Transplantation; Losartan; Male; Middle Aged; Polycythemia | 2002 |
[Uricemia-lowering activity of losartan in kidney transplantation].
Topics: Adult; Cyclosporine; Drug Evaluation; Erythroid Precursor Cells; Erythropoietin; Humans; Immunosuppressive Agents; Kidney Transplantation; Kidney Tubules; Losartan; Middle Aged; Polycythemia; Postoperative Complications; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renal Circulation; Treatment Outcome; Uric Acid | 2002 |
Vasoactive effects of erythropoietin on human placental blood vessels in vitro.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arteries; Captopril; Dose-Response Relationship, Drug; Erythropoietin; Female; Humans; In Vitro Techniques; Losartan; Placental Circulation; Pregnancy; Receptor, Angiotensin, Type 1; Recombinant Proteins; Vasoconstriction; Vasoconstrictor Agents; Veins | 2003 |
Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Captopril; Disease Models, Animal; Drug Therapy, Combination; Erythropoietin; Hydralazine; Hydrochlorothiazide; Hypertension; Kidney; Kidney Failure, Chronic; Losartan; Nephrectomy; Rats; Rats, Wistar; Recombinant Proteins; Renin-Angiotensin System; Reserpine; Time Factors; Uremia | 2006 |
Erythropoietin levels in heart failure after an acute myocardial infarction: determinants, prognostic value, and the effects of captopril versus losartan.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Erythropoietin; Female; Heart Failure; Humans; Losartan; Male; Myocardial Infarction; Prognosis; Retrospective Studies | 2009 |
Angiotensin II type 1 receptor-mediated upregulation of calcineurin activity underlies impairment of cardioprotective signaling in diabetic hearts.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Calcineurin; Diabetes Mellitus, Type 2; Enkephalin, Leucine-2-Alanine; Erythropoietin; Immunosuppressive Agents; Ischemic Preconditioning, Myocardial; Janus Kinase 2; Losartan; Male; Myocardial Reperfusion Injury; Myocardium; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred OLETF; Receptor, Angiotensin, Type 1; Receptors, Opioid, delta; Signal Transduction; Species Specificity; Tacrolimus; Tetrazoles; Up-Regulation; Valine; Valsartan | 2010 |
RAAS blockade in combination with diuretic therapy increases urine excretion, which in turn increases drinking and thus reduces erythropoietin and proteinuria.
Topics: Chronic Disease; Diuretics; Drinking Behavior; Drug Therapy, Combination; Erythropoietin; Hemodilution; Hemoglobins; Humans; Hydrochlorothiazide; Kidney Diseases; Losartan; Proteinuria; Renin-Angiotensin System; Urination | 2010 |